STEPHANIE BENAVIDES: Open Payments
NPI 1922862796 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,173 in 224 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,276 · 2025 $4,173
Food & beverage: $4,173
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 35 | $780 |
| Neurocrine BioSciences, Inc. | 44 | $698 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $395 |
| Otsuka America Pharmaceutical, Inc. | 19 | $341 |
| ABBVIE INC. | 20 | $291 |
| Teva Pharmaceuticals USA, Inc. | 12 | $252 |
| Janssen Pharmaceuticals, Inc | 11 | $242 |
| Alkermes, Inc. | 14 | $202 |
| Lundbeck LLC | 12 | $202 |
| Braeburn Inc. | 8 | $180 |
Products named: Auvelity, INGREZZA, REXULTI, CAPLYTA, VRAYLAR, AUSTEDO XR, SPRAVATO, BRIXADI.
Industry payments across LA — which companies pay providers there.
